🇺🇸 FDA
Patent

US 10512691

Systems and methods for targeted imaging and ablation of cardiac cells

granted A61KA61K31/5415A61K31/704

Quick answer

US patent 10512691 (Systems and methods for targeted imaging and ablation of cardiac cells) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/5415, A61K31/704, A61K33/243, A61K38/10